Skip to content
Last session
PDI $14.38 ▲2.86%D 2.7%DXYZ $28.88 ▼3.86%D 15.8%GOF $8.60 ▲1.44%D 13.5%VCX $25.44 ▲0.24%D 33.3%NEA $10.04 ▲2.53%D 1.9%PTY $10.82 ▲2.08%D 0.4%CLM $6.27 ▼0.61%P 0.0%NAD $10.32 ▲2.59%D 2.4%BCAT $13.14 ▼0.83%D 11.8%JPC $6.80 ▲2.06%D 7.9%PDO $11.94 ▲1.88%D 2.0%UTG $35.05 ▼1.04%D 1.4%BPRE $12.49 ▼0.48%D 46.9%NVG $10.83 ▲2.55%D 2.1%NZF $10.97 ▲2.88%D 1.5%BOT $26.18 ▼3.71%P 256.7%NMZ $9.11 ▲2.65%D 0.7%NAC $10.10 ▲2.74%D 2.1%CRF $5.93 ▼0.38%D 2.6%OXLC $8.36 ▲1.70%MQY $10.20 ▲3.01%D 7.2%UTF $25.53 ▲0.04%D 3.1%ECAT $13.57 ▲0.63%RQI $11.15 ▲1.55%D 8.0%HYT $7.74 ▲1.15%D 11.1%NUV $8.23 ▲1.51%D 4.0%DNP $9.83 ▼0.25%P 6.4%USA $5.98 ▲1.87%D 11.1%ADX $25.79 ▲0.55%D 2.9%MHD $10.34 ▲2.47%D 9.4%DSL $9.78 ▲1.45%D 9.8%MUC $9.70 ▲1.29%D 8.6%TYG $38.43 ▼1.31%D 9.8%MYI $9.78 ▲3.33%D 7.5%JFR $7.32 ▲1.36%D 10.2%BSTZ $27.95 ▼0.56%PCN $10.70 ▲1.90%D 1.5%ASGI $19.33 ▲0.78%D 8.9%EVV $8.35 ▲1.46%D 12.2%PHK $4.08 ▲1.49%D 4.0%

Which closed-end funds own Teva Pharmaceuticals Ne?

10 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $6.5M. Security type: debt security. Country: Netherlands. CUSIP 88167AAR2 · ISIN US88167AAR23.

Holdings are historical filings (report dates May 29, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.

Funds holding this security

FundCategoryWeightValue (USD)BalanceFund net assetsPrem/discReport date
IGI Western Asset Investment Grade Opportunity TrustInvestment Grade0.34%$361K320,000 par$105M7.7% discountMay 29, 2026
PPT Franklin Premier Income TrustTaxable Bonds0.28%$1.1M989,000 par$390M9.6% discountJul 31, 2026
PIM Franklin Master Intermediate Income TrustInvestment Grade0.25%$506K449,000 par$199M8.9% discountJun 30, 2026
ERC Allspring Multi-Sector Income FundMulti-Asset0.25%$997K900,000 par$392M10.7% discountJul 31, 2026
EMD Western Asset Emerging Markets Debt FundTaxable Bonds0.22%$1.8M1,630,000 par$852M12.4% discountJun 30, 2026
PAI Western Asset Investment Grade Income FundInvestment Grade0.18%$226K200,000 par$123M9.8% discountJun 30, 2026
ERH Allspring Utilities & High Income FundHigh Yield0.18%$259K230,000 par$144M11.8% discountMay 31, 2026
FT Franklin Universal TrustU.S. Equity0.12%$339K300,000 par$280M14.3% discountMay 31, 2026
EOD Allspring Global Dividend Opportunity FundGlobal Equity0.08%$277K250,000 par$352M10.2% discountJul 31, 2026
AWF AllianceBernstein Global High Income FundHigh Yield0.06%$571K506,000 par$982M13.1% discountJun 30, 2026

10 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.

Also listed in filings as: TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV; Teva Pharmaceutical Finance Netherlands III BV.

Related securities from the same issuer

SecurityTypeFunds holding
Teva Pharmaceuticals Nedebt security7
Teva Pharmaceuticals Nedebt security2
Teva Pharmaceuticals Nedebt security2
Teva Pharmaceuticals Nedebt security1
Teva Pharmaceuticals Nedebt security1
Teva Pharmaceuticals Nedebt security1

Issuer-level search for “TEVA PHARMACEUTICALS NE” → · Compare two funds’ portfolios →